SEC Filing Details
Document Details
Form
Filing Date
May 15, 2024
Document Date
Mar 31, 2024
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Theravance Biopharma
Issuer
Theravance Biopharma, Inc.